EULAR COVID-19 Clinic visit guidelines

EULAR represents guidance that is intended for clinicians during the COVID-19 pandemic.
Learn how you can contribute to a safe clinic and increase the protection of yourself and others.

EULAR Recommendations 2020

Read the latest:

- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

EULAR Feedback on the EU Pharmaceuticals Strategy Roadmap

EULAR welcomes the initiative of the European Commission to modernise and update the existing regulatory framework for pharmaceutical products in the European Union. 

Registration to EULAR 2020 E-CONGRESS

Join our major event in the world of Rheumatology!

Registration to the EULAR E-CONGRESS 2020 remains open. 
Register and get your access to the scientific sessions until 31 August 2020!

EULAR Press releases

Read the latest:

- Rheumatoid Arthritis Patients under Treatment with Methotrexate: Immunosuppressant Treatment does not confirm negative Effects on Lung Conditions in Patients

- Early and intensive Treatment of rheumatoid Arthritis reduces Fatigue

EULAR Centres of Excellence Call

EULAR invites centres of rheumatology research in Europe to apply for recognition as "EULAR Centre of Excellence in Rheumatology", this time for the period 2020 - 2025.

The EULAR - COVID-19 Reporting Database for rheumatologists and other clinicians

To report cases of COVID-19 in patients with RMDs

Rheumatic Musculoskeletal Diseases and COVID-19

The EULAR guidances and an array of useful resources about the current COVID-19 outbreak to give our patients with Rheumatic Musculoskeletal Diseases (RMDs) the best possible care.

EULAR events and COVID-19

EULAR holds a variety of events throughout Europe, please read the full statement for more details on events' status.